170 related articles for article (PubMed ID: 1457295)
1. Hypothalamo-pituitary-adrenal axis suppression in asthmatic adults taking high dose beclomethasone dipropionate.
Brown PH; Greening AP; Crompton GK
Br J Clin Pract; 1992; 46(2):102-4. PubMed ID: 1457295
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamo-pituitary-adrenal axis function in asthmatics taking low dose inhaled beclomethasone dipropionate.
Gupta D; Behera D; Lalrinmawia H; Dash RJ
J Assoc Physicians India; 2000 Jul; 48(7):682-4. PubMed ID: 11273501
[TBL] [Abstract][Full Text] [Related]
3. [Treatment modalities and hypothalamo-pituitary-adrenal (HPA) axis suppression in Japanese patients with asthma].
Hasegawa T; Ishihara K; Matsumoto H; Tomioka H; Okazaki M; Katakami N; Sakamoto H; Umeda B; Katayama S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Aug; 32(8):757-62. PubMed ID: 7807754
[TBL] [Abstract][Full Text] [Related]
4. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner.
Grebe SK; Feek CM; Durham JA; Kljakovic M; Cooke RR
Clin Endocrinol (Oxf); 1997 Sep; 47(3):297-304. PubMed ID: 9373450
[TBL] [Abstract][Full Text] [Related]
5. Pituitary-adrenal function in asthmatic patients treated with high dose of beclomethasone.
Francia G; Senna GE; Betteli C; Musumeci C; Fratta-Pasini A; Piubello G; Gani F; Mezzelani P; Andri L
Allerg Immunol (Paris); 1994 Jan; 26(1):11-5. PubMed ID: 8166935
[TBL] [Abstract][Full Text] [Related]
6. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
Brannan MD; Herron JM; Reidenberg P; Affrime MB
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):501-10. PubMed ID: 1775677
[TBL] [Abstract][Full Text] [Related]
8. Study on serum and urinary cortisol levels of asthmatic patients after treatment with high dose inhaled beclomethasone dipropionate or budesonide.
Kaur C; Bansal SK; Chhabra SK
Indian J Chest Dis Allied Sci; 2005; 47(2):89-95. PubMed ID: 15832952
[TBL] [Abstract][Full Text] [Related]
9. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[TBL] [Abstract][Full Text] [Related]
10. Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function.
Brown PH; Greening AP; Crompton GK
Thorax; 1993 Mar; 48(3):233-8. PubMed ID: 8497821
[TBL] [Abstract][Full Text] [Related]
11. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
12. Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone.
Kokron CM; Castro AS; Solé D; Naspitz CK
J Investig Allergol Clin Immunol; 1997; 7(1):51-6. PubMed ID: 9093935
[TBL] [Abstract][Full Text] [Related]
13. Influence of high dose inhaled steroids on hypothalamo-pituitary-adrenal axis function in Japanese patients with asthma: a comparison over the course of time.
Hasegawa T; Ishihara K; Fujii H; Hajiro T; Watanabe I; Nishimura T; Okazaki M; Katakami N; Umeda B
Intern Med; 1996 May; 35(5):362-6. PubMed ID: 8797047
[TBL] [Abstract][Full Text] [Related]
14. Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate.
Katsunuma T; Akasawa A; Iikura Y
Ann Allergy; 1992 Dec; 69(6):529-32. PubMed ID: 1471788
[TBL] [Abstract][Full Text] [Related]
15. [The long-term effect of high-dose beclomethasone dipropionate on the pituitary-adrenal function].
Tabe K; Nagata M; Yamamoto H; Kuramitsu K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
Arerugi; 1992 Jun; 41(6):662-7. PubMed ID: 1332654
[TBL] [Abstract][Full Text] [Related]
16. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
[TBL] [Abstract][Full Text] [Related]
17. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?
Brown PH; Blundell G; Greening AP; Crompton GK
Thorax; 1990 Oct; 45(10):736-9. PubMed ID: 2247863
[TBL] [Abstract][Full Text] [Related]
18. [Effect of low dose of inhaled corticosteroid combined with small dose of oral theophylline on treatment of bronchial asthma].
Li J; Mo H; Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):336-9. PubMed ID: 11778513
[TBL] [Abstract][Full Text] [Related]
19. [High-dose inhaled beclomethasone in long-term management of chronic severe asthma--usefulness and dose-dependence].
Kudo K; Tanabe N; Kabe J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):536-44. PubMed ID: 8753111
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
